CARA
Closed
Cara Therapeutic
5.32
-0.23 (-4.14%)
Last Update: 15 Apr 2025 23:00:00
Yesterday: 5.5499
Day's Range: 5.2812 - 5.52
Send
sign up or login to leave a comment!
When Written:
4.91
Cara Therapeutics is a biopharmaceutical company that develops and commercializes novel therapeutics to treat pain and pruritus (itching) associated with various medical conditions. The company's lead product candidate is Korsuva (CR845/difelikefalin), a kappa opioid receptor agonist, which is being developed for the treatment of chronic kidney disease-associated pruritus (CKD-aP) and chronic liver disease-associated pruritus (CLD-aP).
Cara Therapeutics was founded in 2004 and is headquartered in Stamford, Connecticut. The company has partnerships with several pharmaceutical companies, including Vifor Pharma, Maruishi Pharmaceutical, and Enteris BioPharma, for the development and commercialization of its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Cara Therapeutics was founded in 2004 and is headquartered in Stamford, Connecticut. The company has partnerships with several pharmaceutical companies, including Vifor Pharma, Maruishi Pharmaceutical, and Enteris BioPharma, for the development and commercialization of its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








